We are live on ! Find out more
GDRX icon

GoodRx Holdings

159 hedge funds and large institutions have $916M invested in GoodRx Holdings in 2024 Q1 according to their latest regulatory filings, with 38 funds opening new positions, 51 increasing their positions, 39 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

73% more first-time investments, than exits

New positions opened: 38 | Existing positions closed: 22

70% more call options, than puts

Call options by funds: $4.26M | Put options by funds: $2.51M

31% more repeat investments, than reductions

Existing positions increased: 51 | Existing positions reduced: 39

11% more funds holding

Funds holding: 143159 (+16)

5% less capital invested

Capital invested by funds: $965M → $916M (-$49.2M)

17.55% less ownership

Funds ownership: 155.84%138.28% (-18%)

25% less funds holding in top 10

Funds holding in top 10: 43 (-1)

Holders
159
Holders Change
+16
Holders Change %
+11.19%
% of All Funds
2.29%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.04%
New
38
Increased
51
Reduced
39
Closed
22
Calls
$4.26M
Puts
$2.51M
Net Calls
+$1.75M
Net Calls Change
+$1.37M
Name Holding Trade Value Shares
Change
Change in
Stake
CMF
76
Counterpoint Mutual Funds
California
$246K +$99.6K +15,052 +77%
OQS
77
Occudo Quantitative Strategies
Florida
$240K +$224K +33,800 New
Janus Henderson Group
78
Janus Henderson Group
United Kingdom
$233K +$304 +46 +0.1%
TRCT
79
Tower Research Capital (TRC)
New York
$229K +$208K +31,468 +3,943%
GL
80
Gerber LLC
Ohio
$222K +$132K +20,000 +179%
SOW
81
State of Wyoming
Wyoming
$221K -$111K -16,720 -35%
CC
82
Centiva Capital
New York
$210K +$86.6K +13,094 +79%
Barclays
83
Barclays
United Kingdom
$209K +$62.7K +9,483 +48%
Voloridge Investment Management
84
Voloridge Investment Management
Florida
$199K +$185K +27,995 New
Victory Capital Management
85
Victory Capital Management
Texas
$198K -$25.6K -3,877 -12%
Invesco
86
Invesco
Georgia
$192K -$18.7K -2,833 -10%
B
87
Bailard
California
$165K +$153K +23,200 New
CC
88
Corton Capital
Ontario, Canada
$163K +$152K +22,975 New
Squarepoint
89
Squarepoint
New York
$156K +$145K +21,937 New
ASRS
90
Arizona State Retirement System
Arizona
$153K +$2.8K +423 +2%
XT
91
XTX Topco
Cayman Islands
$147K +$137K +20,759 New
Verition Fund Management
92
Verition Fund Management
Connecticut
$145K +$135K +20,397 New
LPL Financial
93
LPL Financial
California
$139K -$17.8K -2,695 -12%
EC
94
EntryPoint Capital
New York
$132K +$76.4K +11,548 +165%
YIH
95
Y-Intercept (HK)
Hong Kong
$131K -$77.8K -11,767 -39%
RIP
96
RAM Investment Partners
Washington
$124K +$7 +1 +0%
GAM
97
Gotham Asset Management
New York
$122K -$12.1K -1,834 -10%
Royal Bank of Canada
98
Royal Bank of Canada
Ontario, Canada
$121K -$198K -29,983 -64%
AQR Capital Management
99
AQR Capital Management
Connecticut
$117K -$255K -38,593 -70%
Zurich Cantonal Bank
100
Zurich Cantonal Bank
Switzerland
$114K

GDRX Hedge Fund Activity: Q1 2024 in Review

159 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in GoodRx Holdings (GDRX) for Q1 2024, worth a combined $916M — down 5.1% from $965M a quarter earlier.

Buyers outnumbered sellers: 38 funds opened new GDRX positions and 22 closed out — a net gain of 16 holders — while 51 added to existing stakes and 39 trimmed.

The largest buyer was Millennium Management, adding an estimated $15.8M. The largest seller was Francisco Partners Management, cutting an estimated $96.7M.

  • 159 institutional investors held GoodRx Holdings (GDRX) as of Q1 2024, up from 143 in Q4 2023.
  • Funds reported $916M of GoodRx Holdings stock for Q1 2024, down 5.1% quarter-over-quarter.
  • 38 funds opened new GoodRx Holdings positions in Q1 2024 and 22 closed out, a net change of +16 holders.
  • The largest GoodRx Holdings buyer in Q1 2024 was Millennium Management, an estimated $15.8M added.
  • The largest GoodRx Holdings seller in Q1 2024 was Francisco Partners Management, an estimated $96.7M sold.

Based on aggregated 13F filings for Q1 2024.